Author

A. Hazra

Observed name: Animesh Hazra

Institution: S.N. Bose National Centre for Basic Sciences

Observed institutions: Pfizer (United States), S.N. Bose National Centre for Basic Sciences

ORCID: 0009-0000-4266-5199

Observed ORCID: 0009-0000-4266-5199

OpenAlex ID: A5060809503

THU0178 Relationship Between NK Cell Count and Important Safety Events in Rheumatoid Arthritis Patients Treated with Tofacitinib

2015 · R.F. van Vollenhoven, Y. Tanaka, et al. · Annals of the Rheumatic Diseases · 13

THU0199 Tofacitinib, An Oral Janus Kinase Inhibitor, in The Treatment of Rheumatoid Arthritis: Changes in Lymphocytes and Lymphocyte Subset Counts and Reversibility after Up To 8 Years of Tofacitinib Treatment

2016 · R. van Vollenhoven, E. Choy, et al. · Annals of the Rheumatic Diseases · 8

Hyperuniformity in mass transport processes with center-of-mass conservation: some exact results

2025 · Animesh Hazra, Anirban Mukherjee, et al. · Journal of Statistical Mechanics Theory and Experiment · 7

DOP074 Pharmacokinetics and exposure-response of tofacitinib in a Phase 3 maintenance study in ulcerative colitis patients

2017 · A. Mukherjee, G.R. D'Haens, et al. · Journal of Crohn s and Colitis · 5

THU0143 Pharmacokinetics, Bioavailability and Safety of A Modified Release Once Daily Formulation of Tofacitinib in Healthy Volunteers

2014 · M. Lamba, R. Wang, et al. · Annals of the Rheumatic Diseases · 2

Fri0465 Tofacitinib Population Pharmacokinetics in Children With Juvenile Idiopathic Arthritis: a Pooled Analysis of Data From Three Clinical Studies

2020 · C. Vong, X. Wang, et al. · Annals of the Rheumatic Diseases · 1

Biopharmaceutical-Based Pharmacokinetic Modeling of Sulopenem Prodrugs: Impact of Luminal Stability on Fraction of Dose Absorbed

2003 · John P. O’Donnell, Katherine E. Brighty, et al. · 46th Annual Meeting · 1

Generic power laws in higher-dimensional lattice models with multidirectional hopping

2025 · Animesh Hazra, Tanmoy Chakraborty, et al. · Physical review. E

AB0879 Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Paediatric Patients from Two To Less than Eighteen Years of Age with Juvenile Idiopathic Arthritis

2016 · N. Ruperto, H.I. Brunner, et al. · Annals of the Rheumatic Diseases

Works count: 10

Citation count: 37

H-index: 4

I10-index: 1